Welcome to LookChem.com Sign In|Join Free

CAS

  • or

149806-05-3

149806-05-3

Post Buying Request

149806-05-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

149806-05-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 149806-05-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,8,0 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 149806-05:
(8*1)+(7*4)+(6*9)+(5*8)+(4*0)+(3*6)+(2*0)+(1*5)=153
153 % 10 = 3
So 149806-05-3 is a valid CAS Registry Number.

149806-05-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-bromo-N-methoxy-N-methylpyridine-3-carboxamide

1.2 Other means of identification

Product number -
Other names 6-BROMO-N-METHOXY-N-MRTHYLPYRIDINE-3-CARBOXAMIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:149806-05-3 SDS

149806-05-3Relevant articles and documents

NOVEL COMPOUNDS HAVING EFFECTS OF TREATING INFLAMMATORY DISEASE AS P38 MAP KINASE INHIBITOR

-

, (2021/10/27)

The present invention relates to novel compounds exhibiting anti-inflammatory activity. The compound of the present invention plays a critical role in the production of inflammatory prodrug (pro-inflammatory cytokines) and has an excellent inhibitory effe

PIPERIDINE COMPOUNDS AS PCSK9 INHIBITORS

-

Paragraph 0445; 0446; 0447, (2018/11/21)

One aspect of the invention relates to a series of new PCSK9 inhibitor compounds comprising piperidine ring structures, including compounds of formula (I) and/or pharmaceutically acceptable salts thereof. Another aspect of the invention relates to methods of treating PCSK9 receptor related diseases comprising administration of one or more compounds of formula (I) or a pharmaceutically acceptable salt thereof.

ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF

-

Paragraph 0279, (2013/06/28)

This invention relates to novel alkyne-bridged hetero-aromatics as described in the specification which are PDE10A inhibitors and useful for the treatment of neurological, psychiatric disorder, metabolic disorders, such as Schizophrenia, Parkinson's disea

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 149806-05-3